Literature DB >> 26100988

Serum Ischemia-Modified Albumin Levels in Experimental Model of Acute Pancreatitis.

Naci Topaloglu1, Adem Kucuk2, Mustafa Tekin1, Sule Yildirim1, Mesut Erbas3, Hasan Ali Kiraz3, Dilek Ulker Cakir4, Havva Erdem5.   

Abstract

OBJECTIVE: To establish whether the Ischemia-Modified Albumin (IMA), a new parameter of oxidative stress, has diagnostic role in experimental acute pancreatitis. STUDY
DESIGN: Randomized controlled trial. PLACE AND DURATION OF STUDY: Experimental Animal Center, Çanakkale Onsekiz Mart University, Çanakkale, Turkey, from May to September 2013.
METHODOLOGY: Sixteen Sprague-Dawley rats were randomly divided into two groups (n=8 each): Sham and AP groups. AP was induced by ligation of pancreatic duct. Serum IMA, amylase, lipase, AST, ALT and CRP were determined. The severity of pancreatitis was scored by a blinded pathologist under microscope.
RESULTS: Serum IMA levels in the AP group increased significantly compared with the control group (p < 0.05). There was also a strong positive correlation between amylase and IMA levels.
CONCLUSION: The present study showed in a rodent model that serum IMA might serve as an additional marker to monitor inflammation during pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26100988     DOI: 06.2015/JCPSP.395398

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  3 in total

1.  Impaired thiol/disulfide homeostasis in patients with mild acute pancreatitis.

Authors:  Ahmet Uyanıkoğlu; Tevfik Sabuncu; Rukiye Yıldız; Çiğdem Cindioğlu; Adnan Kirmit; Özcan Erel
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

2.  Can Ischemia Modified Albumin (IMA) Levels Be a Predictor of Acute Pancreatitis?

Authors:  Hakan Yarkıcı; Gözde Derviş Hakim; Elif Merve Arı; Harun Akar; Ayfer Çolak
Journal:  Turk J Gastroenterol       Date:  2021-03       Impact factor: 1.852

3.  Is ischemia-modified albumin a reliable tool for the assessment of acute pancreatitis?

Authors:  Abdurrahman Sahin; Semra Turkoglu; Nurettin Tunc; Deccane Duzenci; Ozgen Arslan Solmaz; Ibrahim Halil Bahcecioglu; Mehmet Yalniz
Journal:  Ther Clin Risk Manag       Date:  2018-03-29       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.